ArticleJournal for immunotherapy of cancer2024

Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses.

Bo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.